Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast

Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	Price	Price Target	Upside/Downside	Consensus	Analysts	Fore. Revenue Growth	Fore. Earnings Growth	Forecast ROE	Forecast ROA
INCY	INCYTE CORP	$11.62B	$51.74	$74.69	44.36%	Buy	13	11.48%	52.77%	N/A	N/A
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.66B	$29.23	$37.33	27.72%	Buy	6	17.13%	42.05%	N/A	N/A
SMLR	SEMLER SCIENTIFIC INC	$187.17M	$26.62	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BMY	BRISTOL MYERS SQUIBB CO	$98.80B	$48.86	$55.73	14.05%	Hold	11	-0.06%	31.73%	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$411.06M	$7.57	$20.50	170.81%	Strong Buy	4	-25.11%	N/A	N/A	N/A
INMD	INMODE LTD	$1.46B	$17.36	$27.00	55.53%	Buy	3	2.20%	N/A	N/A	N/A
NBIX	NEUROCRINE BIOSCIENCES INC	$13.83B	$138.97	$144.65	4.09%	Buy	17	15.99%	54.49%	N/A	N/A
PGNY	PROGYNY INC	$3.15B	$32.60	$47.00	44.17%	Strong Buy	4	19.15%	20.24%	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$127.43M	$1.88	$11.00	485.11%	Buy	5	-49.09%	142.34%	N/A	N/A
CNC	CENTENE CORP	$40.75B	$76.19	$89.00	16.81%	Strong Buy	6	-0.62%	44.17%	N/A	N/A
SDGR	SCHRODINGER INC	$1.74B	$24.04	$38.50	60.15%	Buy	8	24.55%	51.70%	N/A	N/A
UTHR	UNITED THERAPEUTICS CORP	$11.15B	$237.00	$298.00	25.74%	Strong Buy	7	9.49%	8.78%	N/A	N/A
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$354.95M	$15.04	N/A	N/A	N/A	N/A	11.61%	N/A	N/A	N/A
GILD	GILEAD SCIENCES INC	$83.57B	$67.08	$80.70	20.30%	Hold	10	2.08%	15.64%	N/A	N/A
JNJ	JOHNSON & JOHNSON	$357.77B	$148.53	$176.88	19.08%	Buy	8	3.28%	-6.22%	42.89%	17.60%
CORT	CORCEPT THERAPEUTICS INC	$2.33B	$22.48	$39.33	74.97%	Strong Buy	3	16.94%	29.98%	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$405.88M	$5.50	$6.83	24.24%	Buy	3	-52.28%	N/A	N/A	N/A
DCGO	DOCGO INC	$366.68M	$3.52	$9.80	178.41%	Strong Buy	5	9.32%	315.76%	N/A	N/A
VMD	VIEMED HEALTHCARE INC	$313.54M	$8.09	N/A	N/A	N/A	N/A	N/A	N/A	14.29%	10.51%
CCRN	CROSS COUNTRY HEALTHCARE INC	$610.13M	$17.57	$20.80	18.38%	Buy	5	-13.31%	25.69%	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$615.65M	$8.66	N/A	N/A	N/A	N/A	36.23%	-24.21%	N/A	N/A
PCRX	PACIRA BIOSCIENCES INC	$1.20B	$25.90	$47.57	83.67%	Strong Buy	7	7.45%	90.49%	N/A	N/A
STAA	STAAR SURGICAL CO	$2.34B	$47.82	$44.33	-7.29%	Buy	6	11.06%	139.79%	N/A	N/A
KMDA	KAMADA LTD	$297.74M	$5.18	$11.00	112.36%	Buy	1	15.57%	50.54%	N/A	N/A
PBYI	PUMA BIOTECHNOLOGY INC	$232.84M	$4.83	$7.00	44.93%	Buy	1	0.26%	31.88%	N/A	N/A
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.97B	$41.00	$61.50	50.00%	Buy	2	15.18%	-11.88%	N/A	N/A
EXEL	EXELIXIS INC	$7.19B	$23.71	$27.17	14.58%	Buy	6	8.37%	55.63%	N/A	N/A
HALO	HALOZYME THERAPEUTICS INC	$4.96B	$39.12	$54.17	38.46%	Buy	6	15.95%	48.53%	N/A	N/A
HCM	HUTCHMED (CHINA) LTD	$3.21B	$18.41	$19.55	6.19%	Buy	2	4.03%	33.58%	N/A	N/A
DOCS	DOXIMITY INC	$4.46B	$23.91	$27.88	16.58%	Sell	8	10.99%	33.42%	N/A	N/A
RPRX	ROYALTY PHARMA PLC	$16.72B	$27.98	$46.75	67.08%	Strong Buy	4	11.31%	34.87%	N/A	N/A
MCK	MCKESSON CORP	$70.36B	$535.42	$555.22	3.70%	Strong Buy	9	10.70%	25.95%	N/A	N/A
EW	EDWARDS LIFESCIENCES CORP	$53.25B	$88.61	$89.55	1.06%	Buy	11	9.16%	26.57%	N/A	N/A
CHE	CHEMED CORP	$9.34B	$617.95	$681.00	10.20%	Buy	2	6.62%	21.67%	N/A	N/A
MDT	MEDTRONIC PLC	$106.73B	$80.38	$94.00	16.94%	Buy	5	2.75%	27.64%	N/A	N/A
AZN	ASTRAZENECA PLC	$220.74B	$71.20	$82.50	15.87%	Strong Buy	2	8.23%	45.14%	N/A	N/A
ASTH	ASTRANA HEALTH INC	$2.05B	$37.01	$48.00	29.69%	Strong Buy	3	19.24%	N/A	N/A	N/A
TGTX	TG THERAPEUTICS INC	$2.16B	$13.98	$30.20	116.02%	Strong Buy	5	38.43%	139.09%	N/A	N/A
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.13B	$35.48	$38.60	8.79%	Strong Buy	5	-0.27%	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$8.78B	$10.90	$17.11	56.98%	Strong Buy	9	77.28%	N/A	N/A	N/A
NSYS	NORTECH SYSTEMS INC	$47.65M	$17.39	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MDXG	MIMEDX GROUP INC	$944.94M	$6.43	$12.67	97.00%	Strong Buy	3	11.82%	25.46%	N/A	N/A
GMAB	GENMAB A	$18.81B	$28.47	$45.00	58.06%	Buy	4	21.76%	48.09%	N/A	N/A
ISRG	INTUITIVE SURGICAL INC	$133.02B	$375.01	$407.80	8.74%	Strong Buy	15	13.21%	-11.57%	N/A	N/A
SEM	SELECT MEDICAL HOLDINGS CORP	$3.56B	$27.72	$32.50	17.24%	Buy	2	4.14%	65.79%	N/A	N/A
LNTH	LANTHEUS HOLDINGS INC	$4.47B	$65.21	$96.20	47.52%	Strong Buy	5	8.54%	-17.80%	N/A	N/A
UTMD	UTAH MEDICAL PRODUCTS INC	$241.04M	$67.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CVS	CVS HEALTH CORP	$85.29B	$67.77	$88.60	30.74%	Strong Buy	10	4.99%	37.17%	N/A	N/A
TALK	TALKSPACE INC	$518.53M	$3.07	$3.00	-2.28%	Hold	1	28.43%	N/A	45.55%	38.00%
ADUS	ADDUS HOMECARE CORP	$1.55B	$95.50	$102.60	7.43%	Buy	5	6.34%	N/A	N/A	N/A
SLP	SIMULATIONS PLUS INC	$932.30M	$46.65	$51.00	9.32%	Buy	1	20.59%	35.55%	N/A	N/A
VEEV	VEEVA SYSTEMS INC	$32.35B	$200.52	$239.00	19.19%	Buy	18	13.93%	24.04%	N/A	N/A
IRMD	IRADIMED CORP	$537.41M	$42.44	$65.00	53.16%	Strong Buy	1	11.53%	N/A	N/A	N/A
BRKR	BRUKER CORP	$11.32B	$82.20	$85.67	4.22%	Buy	6	8.93%	0.00%	N/A	N/A
MEIP	MEI PHARMA INC	$21.72M	$3.26	$7.00	114.72%	Hold	1	-42.12%	N/A	N/A	N/A
COR	CENCORA INC	$47.47B	$237.95	$235.00	-1.24%	Buy	4	6.28%	27.05%	N/A	N/A
ICLR	ICON PLC	$25.59B	$309.44	$346.43	11.95%	Strong Buy	7	6.28%	31.77%	N/A	N/A
CAH	CARDINAL HEALTH INC	$25.18B	$103.54	$113.17	9.30%	Buy	6	4.13%	71.17%	N/A	N/A
BMRN	BIOMARIN PHARMACEUTICAL INC	$17.21B	$91.20	$103.44	13.43%	Strong Buy	9	12.22%	94.71%	N/A	N/A
DXCM	DEXCOM INC	$53.15B	$137.87	$149.71	8.59%	Strong Buy	7	17.89%	11.30%	N/A	N/A
SNY	SANOFI	$117.90B	$46.61	$55.00	18.00%	Hold	1	5.09%	35.94%	N/A	N/A
CI	CIGNA GROUP	$102.99B	$352.28	$375.54	6.60%	Strong Buy	13	9.55%	41.67%	N/A	N/A
LMAT	LEMAITRE VASCULAR INC	$1.43B	$64.03	$69.00	7.76%	Buy	1	8.39%	9.48%	N/A	N/A
ALC	ALCON INC	$39.25B	$79.57	$92.07	15.71%	Strong Buy	9	5.99%	32.06%	N/A	N/A
MOH	MOLINA HEALTHCARE INC	$21.46B	$367.41	$417.71	13.69%	Buy	7	12.57%	21.44%	N/A	N/A
AMN	AMN HEALTHCARE SERVICES INC	$2.17B	$57.19	$74.20	29.74%	Buy	5	-6.41%	27.89%	N/A	N/A
OPCH	OPTION CARE HEALTH INC	$5.20B	$29.93	$38.00	26.96%	Strong Buy	2	7.66%	-36.86%	N/A	N/A
PODD	INSULET CORP	$11.70B	$167.25	$224.67	34.33%	Buy	6	17.37%	14.90%	N/A	N/A
ALGN	ALIGN TECHNOLOGY INC	$23.57B	$313.78	$331.33	5.59%	Buy	6	8.12%	51.26%	N/A	N/A
GMED	GLOBUS MEDICAL INC	$6.96B	$51.44	$63.00	22.47%	Buy	6	22.07%	35.47%	N/A	N/A
ZBH	ZIMMER BIOMET HOLDINGS INC	$24.85B	$121.17	$133.20	9.93%	Hold	10	4.58%	22.70%	N/A	N/A
HUM	HUMANA INC	$38.08B	$315.98	$427.19	35.19%	Buy	16	3.47%	57.24%	N/A	N/A
ATRC	ATRICURE INC	$1.10B	$23.05	$48.00	108.24%	Strong Buy	6	15.00%	N/A	N/A	N/A
UNH	UNITEDHEALTH GROUP INC	$449.26B	$487.30	$567.64	16.49%	Strong Buy	14	7.06%	12.68%	39.39%	12.77%
THC	TENET HEALTHCARE CORP	$9.83B	$98.26	$103.75	5.59%	Strong Buy	12	1.13%	32.93%	N/A	N/A
GSK	GSK PLC	$82.86B	$40.86	$46.00	12.58%	Buy	2	4.92%	34.02%	N/A	N/A
ABT	ABBOTT LABORATORIES	$185.47B	$106.89	$127.67	19.44%	Strong Buy	6	5.75%	23.18%	N/A	N/A
HOLX	HOLOGIC INC	$18.01B	$76.71	$83.43	8.76%	Buy	7	3.88%	50.45%	N/A	N/A
FONR	FONAR CORP	$108.65M	$16.19	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PEN	PENUMBRA INC	$7.98B	$206.15	$274.71	33.26%	Strong Buy	7	17.30%	-24.53%	N/A	N/A
KIDS	ORTHOPEDIATRICS CORP	$734.74M	$31.20	$37.17	19.13%	Buy	6	26.25%	N/A	N/A	N/A
STE	STERIS PLC	$20.04B	$202.80	$239.60	18.15%	Buy	5	7.08%	52.45%	N/A	N/A
ATR	APTARGROUP INC	$9.24B	$140.01	$155.00	10.71%	Strong Buy	2	2.39%	10.53%	N/A	N/A
NVS	NOVARTIS AG	$200.67B	$98.35	$115.00	16.93%	Hold	2	1.25%	2.37%	N/A	N/A
BNTX	BIONTECH SE	$20.94B	$88.09	$114.71	30.22%	Hold	7	-8.96%	36.84%	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$262.37M	$4.56	N/A	N/A	N/A	N/A	13.15%	102.06%	N/A	N/A
WST	WEST PHARMACEUTICAL SERVICES INC	$28.27B	$385.73	$442.75	14.78%	Strong Buy	4	5.35%	25.46%	N/A	N/A
STRR	STAR EQUITY HOLDINGS INC	$13.71M	$0.87	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HSIC	HENRY SCHEIN INC	$9.41B	$73.21	$80.11	9.43%	Buy	9	6.18%	49.68%	N/A	N/A
BTMD	BIOTE CORP	$416.63M	$5.59	$8.39	50.05%	Strong Buy	4	13.93%	140.57%	N/A	N/A
TFX	TELEFLEX INC	$9.94B	$211.17	$260.14	23.19%	Buy	7	5.02%	35.89%	N/A	N/A
MMSI	MERIT MEDICAL SYSTEMS INC	$4.29B	$74.03	$93.00	25.62%	Buy	8	5.19%	67.48%	N/A	N/A
IDXX	IDEXX LABORATORIES INC	$41.07B	$494.26	$584.00	18.16%	Buy	5	9.73%	9.78%	N/A	N/A
ZTS	ZOETIS INC	$69.08B	$150.88	$215.20	42.63%	Strong Buy	5	6.78%	12.79%	N/A	N/A
PINC	PREMIER INC	$2.53B	$21.12	$24.50	16.00%	Buy	3	1.68%	52.55%	N/A	N/A
DVA	DAVITA INC	$11.64B	$132.74	$137.67	3.71%	Buy	3	3.66%	40.21%	N/A	N/A
RVTY	REVVITY INC	$12.68B	$102.68	$114.75	11.75%	Buy	8	4.79%	21.89%	N/A	N/A
QTRX	QUANTERIX CORP	$610.54M	$16.04	$32.00	99.50%	Buy	1	15.50%	N/A	N/A	N/A
PLX	PROTALIX BIOTHERAPEUTICS INC	$88.39M	$1.21	$10.00	726.45%	Buy	1	N/A	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$133.27M	$0.69	$10.00	1,347.18%	Buy	1	166.59%	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	683	-0.75%	-1.00%	-8.98%	-23.76%	15.69x	5.86x	-73.76%	+2.89%	+21.36%	+88.37%	Strong Buy
Diagnostics & Research	66	-0.33%	+3.77%	-4.62%	-5.24%	38.76x	4.22x	-21.54%	+6.49%	+11.11%	+9.65%	Buy
Drug Manufacturers - General	17	-0.39%	+1.03%	-3.96%	+10.96%	153.97x	5.95x	+34.41%	+8.16%	+15.00%	+15.96%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.67%	+0.64%	-3.62%	-10.31%	47.66x	2.06x	+10.99%	+2.59%	+4.84%	+38.96%	Strong Buy
Healthcare Plans	12	-0.27%	+2.07%	-2.72%	+3.19%	18.72x	2.91x	+20.03%	+6.14%	+14.20%	+16.28%	Buy
Health Information Services	61	-0.67%	+0.84%	-7.47%	-27.56%	72.14x	3.39x	+6.48%	+2.29%	+5.88%	+37.59%	Buy
Medical Care Facilities	50	+0.08%	+2.70%	-3.56%	+5.08%	-2.13x	4.61x	-89.00%	+6.26%	+13.18%	+14.79%	Buy
Medical Devices	154	-0.03%	+0.47%	-1.97%	-16.84%	30.46x	3.73x	+10.53%	+5.28%	+7.74%	+21.32%	Buy
Medical Distribution	9	+0.33%	+0.85%	-1.20%	+33.87%	26.05x	146.51x	+18.24%	+3.52%	+19.62%	+4.67%	Buy
Medical Instruments & Supplies	56	+0.08%	+2.35%	-3.48%	-13.16%	48.25x	3.52x	+11.58%	+7.71%	+10.10%	+19.56%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top healthcare stock with a Zen Score of 75, which is 50 points higher than the healthcare sector average of 25. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -31.24% over the past year, underperforming other healthcare stocks by -19 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.36% from Incyte's current stock price of $51.74.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -9.81% over the past year, overperforming other healthcare stocks by 2 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.72% from Harmony Biosciences Holdings's current stock price of $29.23.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Bristol Myers Squibb Co (NYSE:BMY)

Bristol Myers Squibb Co (NYSE:BMY) is the third best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 25 out of 38 due diligence checks and has strong fundamentals. Bristol Myers Squibb Co has seen its stock lose -30.73% over the past year, underperforming other healthcare stocks by -19 percentage points.

Bristol Myers Squibb Co has an average 1 year price target of $55.73, an upside of 14.05% from Bristol Myers Squibb Co's current stock price of $48.86.

Bristol Myers Squibb Co stock has a consensus Hold recommendation according to Wall Street analysts. Of the 11 analysts covering Bristol Myers Squibb Co, 9.09% have issued a Strong Buy rating, 0% have issued a Buy, 81.82% have issued a Hold, while 0% have issued a Sell rating, and 9.09% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 73 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.78%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 53.68%, which is 51 percentage points higher than the healthcare sector average of 2.78%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 12.12%, which is 9 percentage points higher than the healthcare sector average of 2.78%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.34% in the last day, and up 1.08% over the last week. Evotec Se was the among the top losers in the healthcare sector, dropping -31.63% yesterday.

Evotec shares are trading lower. The company reported FY23 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 82 points higher than the healthcare sector average of 18. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -53.99% in the past year. It has underperformed other stocks in the healthcare sector by -42 percentage points.

2. Orasure Technologies (NASDAQ:OSUR)

Orasure Technologies (NASDAQ:OSUR) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 82 points higher than the healthcare sector average of 18. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has dropped -21.2% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 82 points higher than the healthcare sector average of 18. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -1.69% in the past year. It has overperformed other stocks in the healthcare sector by 10 percentage points.

Are healthcare stocks a good buy now?

47.45% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 37.63% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 72.76x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.